Table of contents:
Video: Most Russians Consider Lung Cancer Treatment Too Expensive And Therefore Inaccessible
Most Russians consider lung cancer treatment too expensive and therefore inaccessible
VTsIOM presented the results of a survey on the awareness of Russians about the problem of lung cancer and its treatment. According to the majority of respondents, lung cancer is one of the three most common oncological diseases, while its treatment is difficult to access and ineffective. The study was timed to coincide with World Lung Cancer Day, which is celebrated on August 1.
Photo: needpix.com /
Lung cancer is one of the three most common oncological diseases, while its treatment is difficult to access and ineffective. These are the results of a study on the awareness of Russians about the problem of lung cancer and its treatment, which was received by VTsIOM. The all-Russian survey was timed to coincide with World Lung Cancer Day, which is celebrated on August 1.
The poll "VTsIOM-Sputnik" was supported by the Association of Cancer Patients "Hello!" July 20-21, 2019. The survey involved 3200 respondents of all age groups.
The study has shown that the overwhelming majority of Russians (70%) have encountered cancer in their environment. More often about what their friends or relatives ever put oncologic diagnosis, said a representative of the female audience (76%), people aged 35 to 59 years (76%). Another 4% of respondents personally was diagnosed with "cancer".27% of Russians have never encountered cancer, these are mainly men (35%) and young people aged 18-24 (49%).
Lung cancer is one of the three most common diseases faced by Russians in their environment (24%), along with breast cancer (33%) and stomach cancer (25%). Moreover, according to the survey, lung cancer ranks first in prevalence among men (39%), ahead of prostate cancer (30%) and stomach cancer (24%). Women, in the opinion of Russians, are less likely to suffer from lung cancer (8%), the most common among them is breast cancer (68%), as well as stomach cancer (12%) and blood cancer (10%).
Director of the Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Aid" of the Ministry of Health of the Russian Federation, Doctor of Medical Sciences, Professor Vitaly Omelyanovsky:
"Lung cancer is one of the key reasons for the loss of years of life expectancy in men, while stomach and cervical cancer have a similar effect in women. Today, the economic burden of lung cancer is estimated at 14.7 billion rubles per year."
The prevailing opinion among Russians is that all types of cancer are equally difficult to cure (56%). Another 27% of the respondents believe that it is possible to single out individual intractable oncological diseases. Moreover, they put lung cancer in second place (7%) after blood cancer (14%).
The majority of Russians (72%) consider lung cancer treatment too expensive and, therefore, inaccessible to most patients. At the same time, about half of the respondents (48%) are of the opinion that currently there are no effective methods of treatment that can cure this disease.
More than half of Russians (52%) have never heard or know anything about such a cancer treatment method as immunotherapy - mostly people aged 45-59 years (58%). At the same time, 74% of Russians are sure that diagnosing lung cancer in the early stages is easier to treat, which is the most common point of view among young people aged 18-24 (87%).
Deputy Director for Medical Work of the Federal State Budgetary Institution “National Medical Research Center of Oncology named after N.N. Blokhin "of the Ministry of Health of Russia, Doctor of Medical Sciences, Professor Konstantin Laktionov:
“Lung cancer is one of the most aggressive and difficult to detect cancers. Every second patient dies within a year of diagnosis. Most often - in 70% of cases - it is detected already in the late stages (III and IV), when the tumor spreads to neighboring organs or metastases appear. Until recently, treatment options for advanced lung cancer were limited to chemotherapy, which has low efficacy, and targeted therapy, which can be prescribed to no more than 30% of patients. Today in Russia, as well as throughout the world, immunotherapy has also become available. Immuno-oncological drugs are a real breakthrough in medicine, radically changing the approach to cancer treatment - they enhance the natural ability of the immune system to fight against tumors.These drugs can significantly prolong life with advanced lung cancer - in some groups, every third patient gets the opportunity to live five years or more.
According to Russians, the top factors that increase the risk of oncology and development of cancer include: poor ecology (67%), smoking (36%) and unhealthy diet (36%), as well as bad heredity (30%). Another 23% believe that alcohol consumption can increase the risk of cancer.